middle.news
Race Oncology Accelerates RC220 Trial with Second Australian Site Activation
6:42am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Race Oncology Accelerates RC220 Trial with Second Australian Site Activation
6:42am on Monday 2nd of June, 2025 AEST
Key Points
Second clinical trial site activated at Central Coast Local Health District
Phase 1 trial assessing RC220 combined with doxorubicin in advanced solid tumours
Trial uses Bayesian design for flexible and accelerated data collection
Up to 53 patients to be enrolled across Australia, Hong Kong, and South Korea
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
RAC
OPEN ARTICLE